Literature DB >> 29028083

Association between advanced oxidation protein products (AOPP) and vascular calcification in uremic patients.

L Lin1, G-J Zhao, L-L Qin.   

Abstract

OBJECTIVE: To investigate the correlation between serum advanced oxidation protein products (AOPP) and vascular calcification in uremic patients. PATIENTS AND METHODS: The general data of included subjects were collected, and the serum AOPP, intact parathyroid hormone (iPTH), creatinine (Cre), Urea, calcium (Ca), phosphorus (P), total cholesterol (TC), triglyceride (TG), low density lipoprotein cholesterin (LDL-C), hemoglobin (Hb) and albumin (ALB) were detected. Coronary artery computed tomography (CT) scan was performed and the coronary arterial calcification score (CACS) was calculated; the whole abdomen CT scan was performed and abdominal aortic calcification index (AACI) was calculated. SPSS l9.0 software was used for data analysis.
RESULTS: The coronary artery CT and detection of serum indexes showed that AOPP in positive coronary arterial calcification group was significantly increased compared with that in negative coronary arterial calcification group (59.14 ± 14.57 vs. 37.59 ± 5.31) μmol/L. The whole abdomen CT and detection of serum indexes showed that AOPP in positive abdominal aortic calcification group was significantly increased compared with that in negative abdominal aortic calcification group (60.32 ± 15.43 vs. 39.57 ± 6.25) μmol/L. AOPP in severe calcification group was significantly higher than negative group (70.72 ± 18.18 vs. 39.57 ± 6.25) μmol/L. There were no significant differences in AOPP between hypertension and non-hypertension groups, diabetic nephropathy and non-diabetic nephropathy groups. Correlation analysis showed that AOPP of uremic patients had a significantly positive correlation with logl0[CACS+1] and had a significantly positive correlation with inferior AACI.
CONCLUSIONS: AOPP in positive coronary arterial calcification group and positive abdominal aortic calcification group was higher than that in negative group and AOPP in severe calcification group was significantly higher than that in negative group. AOPP of uremic patients has a significantly positive correlation with CACS and AACI.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 29028083

Source DB:  PubMed          Journal:  Eur Rev Med Pharmacol Sci        ISSN: 1128-3602            Impact factor:   3.507


  4 in total

1.  Implications of advanced oxidation protein products and vitamin E in atherosclerosis progression.

Authors:  Leila Azouaou Toualbi; Adnane Mounir; Ballouti Wafa; Arab Medina; Khelfi Abderrezak; Toualbi Chahine; Chader Henni; Bennoui Abdelghani; Seba Atmane
Journal:  Arch Med Sci Atheroscler Dis       Date:  2021-06-30

2.  [Association of plasma level of advanced oxidation protein products with Framingham risk score in type 2 diabetic patients without vascular diseases].

Authors:  Chao Xie; Jie Tian; Wei Li; Min Liang; Yao-Zhong Kong
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2018-05-20

3.  Advanced glycation end products predict long-term outcome of catheter ablation in paroxysmal atrial fibrillation.

Authors:  Allan Bohm; Lubos Urban; Lubomira Tothova; Ljuba Bacharova; Peter Musil; Jan Kyselovic; Peter Michalek; Tomas Uher; Branislav Bezak; Peter Olejnik; Robert Hatala
Journal:  J Interv Card Electrophysiol       Date:  2021-03-10       Impact factor: 1.900

4.  The Relationship between Advanced Oxidation Protein Products, Vascular Calcifications and Arterial Stiffness in Predialysis Chronic Kidney Disease Patients.

Authors:  Ion-Vlad Vinereanu; Ileana Peride; Andrei Niculae; Andreea Taisia Tiron; Andra Caragheorgheopol; Dana Manda; Ionel Alexandru Checherita
Journal:  Medicina (Kaunas)       Date:  2021-05-06       Impact factor: 2.430

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.